Central Serous Chorioretinopathy: An Update on the Current State of Management
Klinische Monatsblätter für Augenheilkunde · 01.07.2024 · 241 (07) · 845-862
DOI: 10.1055/a-2062-3751 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.07.2024. Verfasst von Dimitrios Kalogeropoulos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology, University General Hospital of Ioannina, Ioannina, Greece. Hauptthemen laut MEDLINE: Central Serous Chorioretinopathy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 212 Literaturangaben.
Abstract (Originalsprache)
Central serous chorioretinopathy (CSCR) is a relatively common retinal disorder that leads to central vision impairment, often with a high recurrence rate. The exact etiology and pathogenetic mechanisms have not been fully elucidated but are likely to be associated with hyperpermeability of the choroidal capillaries and failure of the retinal pigment epithelium (RPE), leading to serous detachment of the neurosensory retina. Multimodal imaging plays a critical role in the diagnostic approach and monitoring of CSCR. Fortunately, the natural course of the disease is usually self-limiting, with spontaneous resolution and total fluid reabsorption. However, some patients may exhibit recurrences or persistent subretinal fluid (chronic CSCR), leading to progressive and irreversible RPE atrophy or photoreceptor damage. Thus, to prevent permanent visual loss, individualized treatment should be considered. Recent developments in the diagnostic and therapeutic approach have contributed to better outcomes in patients with CSCR. More studies are required to improve our understanding of epidemiology, pathogenesis, diagnosis, and treatment, with a significant impact on the management of this challenging clinical entity. The purpose of this review is to summarize the current knowledge about the clinical features, diagnostic workup, and therapeutic approach of CSCR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Ophthalmology, University General Hospital of Ioannina, Ioannina, Greece.
- Ophthalmology, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, United States.
- Ophthalmology, Birmingham and Midland Eye Centre, Birmingham, United Kingdom of Great Britain and Northern Ireland.
- Ophthalmology, University of Ioannina Faculty of Medicine, Ioannina, Greece.
ORCID-Profile: Dimitrios Kalogeropoulos
Zitieren
APA
Kalogeropoulos, D., Shaw, L., Skondra, D., Ch'ng, S. W., Christodoulou, A., & Kalogeropoulos, C. (2024). Central Serous Chorioretinopathy: An Update on the Current State of Management. Klinische Monatsblätter für Augenheilkunde, 241(07), 845-862. https://doi.org/10.1055/a-2062-3751
Vancouver
Kalogeropoulos D, Shaw L, Skondra D, Ch'ng SW, Christodoulou A, Kalogeropoulos C. Central Serous Chorioretinopathy: An Update on the Current State of Management. Klinische Monatsblätter für Augenheilkunde. 2024;241(07):845-862. doi:10.1055/a-2062-3751
BibTeX
@article{Kalogeropoulos2024,
author = {Kalogeropoulos, Dimitrios and Shaw, Lincoln and Skondra, Dimitra and Ch'ng, Soon Wai and Christodoulou, Aikaterini and Kalogeropoulos, Chris},
title = {Central Serous Chorioretinopathy: An Update on the Current State of Management},
journal = {Klinische Monatsblätter für Augenheilkunde},
year = {2024},
volume = {241},
number = {07},
pages = {845--862},
doi = {10.1055/a-2062-3751}
}
EUVIMED